Rep. Stupak Works To Increase FDA Oversight, Improve Prescription Drug Safety

Friday, February 22nd, 2008

The Wall Street Journal on Wednesday examined House Energy and Commerce Oversight and Investigations Subcommittee Chair Bark Stupak's (D-Mich.) efforts to increase FDA oversight and improve the safety of prescription drugs. According to the Journal, Stupak is "at the center of an aggressive effort by congressional Democrats to spotlight what ...

CLASP Schools - Statement By The Health And Safety Executive, UK

Tuesday, February 19th, 2008

In autumn 2006, the Health and Safety Executive (HSE) identified that there was the potential for asbestos fibres to be released in particular circumstances in CLASP (system built) schools. HSE therefore,took immediate and positive action, advising all relevant dutyholders to visually check their CLASP (system built) school buildings and, where ...

Two Companies Fined For Breaches Of Health And Safety Legislation After Two Workers Seriously Injured, UK

Tuesday, February 19th, 2008

The Health and Safety Executive has again urged construction companies to take sensible, effective precautions to protect employees and others affected by work at height. This follows a sentencing at Aylesbury Crown Court, at which Environmental Reclamation Ltd (ERL) of St Albans, Hertfordshire, was fined a total of £30,000, and ordered ...

Rep. Stupak Calls For FDA Commissioner To Resign Amid Recent Prescription Drug Safety Issues

Monday, February 18th, 2008

House Energy and Commerce Oversight and Investigations Subcommittee Chair Bart Stupak (D-Mich.) on Thursday called on FDA Commissioner Andrew von Eschenbach to resign, saying that he had lost confidence in officials over the handling of investigations and oversight by the agency, the AP/Los Angeles Times reports (Thomas, AP/Los Angeles Times, ...